Journal article
Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease
Abstract
BACKGROUND: Angiotensin-converting-enzyme (ACE) inhibitors are effective in reducing the risk of heart failure, myocardial infarction, and death from cardiovascular causes in patients with left ventricular systolic dysfunction or heart failure. ACE inhibitors have also been shown to reduce atherosclerotic complications in patients who have vascular disease without heart failure.
METHODS: In the Prevention of Events with Angiotensin Converting …
Authors
Braunwald E; Domanski MJ; Fowler SE; Geller NL; Gersh BJ; Hsia J; Pfeffer MA; Rice MM; Rosenberg YD; Rouleau JL
Journal
New England Journal of Medicine, Vol. 351, No. 20, pp. 2058–2068
Publisher
Massachusetts Medical Society
Publication Date
November 11, 2004
DOI
10.1056/nejmoa042739
ISSN
0028-4793